Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2025-09-10 to 2025-09-30
ROUNDS
2
joined, none as lead
ROUNDS JOINED · USD
$418M
across 2 rounds
CO-INVESTORS
17
named beside it
Named on 2 rounds in the feed, most often in Biotech.
Rounds from 2025-09-10 to 2025-09-30
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Crystalys Therapeutics Crystalystx develops therapeutics specifically for treating gout. | Series A Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $205M | 2025-09-30 | [ PART ] |
Odyssey Odyssey Therapeutics develops innovative therapies aimed at transforming the treatment of autoimmune and inflammatory diseases for patients. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $213M | 2025-09-10 | [ PART ] |